Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Induced Pluripotent Stem Cell (iPSC) Market From 2025 to 2034?

The induced pluripotent stem cell (iPSC) market has grown rapidly in recent years. It will grow from $3.3 billion in 2025 to $3.67 billion in 2025, at a CAGR of 11.3%. The growth is attributed to increasing healthcare expenditure, rising funding, growing awareness of the medicinal potential of stem cell products, use of iPSC-based drug discovery, the rising demand for personalized medicine, and cost-effective benefits of iPSCs in drug discovery.

The induced pluripotent stem cell (iPSC) market is expected to see significant growth, reaching $5.29 billion by 2029, at a CAGR of 9.6%. The growth is driven by the rising prevalence of chronic diseases, genomic projects, IPSC-derived disease models, genetic diseases, government initiatives, and technological advancements. Key trends include the development of pluripotent stem cells for Parkinson’s disease, strategic collaborations, IPSC-derived NK cells, and investments in regenerative medicine research.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the induced pluripotent stem cell (ipsc) Market?

The growth of the induced pluripotent stem cell market is largely driven by the increasing prevalence of chronic diseases. Conditions like heart disease, cancer, stroke, and diabetes can be treated with induced pluripotent stem cells, which are derived from tissues of both children and adults and modified to function like embryonic stem cells. According to the Partnership to Fight Chronic Disorder (PFCD), 45% of 133 million Americans have at least one chronic disorder, and approximately 1.7 million deaths per year in the U.S. are caused by chronic illnesses—deaths that could be mitigated with induced pluripotent stem cell treatments. This surge in chronic disease cases is fueling the demand for induced pluripotent stem cell therapies.

Explore Comprehensive Insights Into The Global Induced Pluripotent Stem Cell (iPSC) Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

What Are the Key Industry Players Leading the Charge in the Induced Pluripotent Stem Cell (iPSC) Market’s Growth?

Major companies operating in the induced pluripotent stem cell (iPSC) market include:

• FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics_x000D_

• Inc)_x000D_

• Thermo Fisher Scientific_x000D_

• Inc_x000D_

• Takara Bio_x000D_

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Induced Pluripotent Stem Cell (iPSC) Market?

Companies in the Induced Pluripotent Stem Cell (IPSC) market are exploring opportunities for strategic partnerships and collaborations to expand into new regions and broaden their product offerings. For example, in January 2022, Bristol Myers Squibb and Century Therapeutics formed a strategic collaboration to develop IPSC-derived allogenic cell therapies for treating acute myeloid leukemia and multiple myeloma. Additionally, in May 2022, Evotec and Sernova announced a partnership to develop IPSC-based beta cell replacement therapy for type 1 and type 2 diabetes treatment.

Secure Your Global Induced Pluripotent Stem Cell (iPSC) Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

What Are the Main Segments of the Induced Pluripotent Stem Cell (iPSC) Market, and How Are They Evolving?

The induced pluripotent stem cell (iPSC) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

What Regions Are Influencing the Dynamics of the Induced Pluripotent Stem Cell (iPSC) Market?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Definition of the Induced Pluripotent Stem Cell (iPSC) Market Impacting Future Growth?

Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes, and neurons. This process involves introducing specific genes that induce the cell to become pluripotent, meaning it can differentiate into any cell type in the body (e.g., heart, brain, liver cells).

Browse Through More Similar Reports By The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Stem Cell Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: